Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics and Hepatic Safety of EGCG in Women With and Without Uterine Fibroids
NCT04177693Phase 1Completed
- Sponsor
- Yale University
- Start
- Nov 2020
- Primary completion
- Jan 2022
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of epigallocatechin gallate in Uterine Fibroids (UF), sponsored by Yale University. Started Nov 2020; status: completed.
02
Drugs
epigallocatechin gallate
03
Conditions
Uterine Fibroids (UF)
Beyond the preview
Go deeper on NCT04177693.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04177693.